Global Retirement Partners LLC Has $2.52 Million Stock Holdings in Danaher Corporation $DHR

Global Retirement Partners LLC increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 60.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,985 shares of the conglomerate’s stock after buying an additional 4,151 shares during the period. Global Retirement Partners LLC’s holdings in Danaher were worth $2,515,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Elevated Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth approximately $26,000. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth approximately $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners acquired a new stake in Danaher during the 3rd quarter worth approximately $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.7%

Shares of NYSE DHR opened at $172.12 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company’s 50 day moving average price is $183.52 and its 200-day moving average price is $208.73. The company has a market capitalization of $121.82 billion, a P/E ratio of 33.29, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company earned $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on DHR. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Evercore boosted their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 21st. Wolfe Research dropped their price target on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Barclays dropped their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Finally, TD Cowen dropped their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $238.65.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.